Latent cluster analysis of ALS phenotypes identifies prognostically differing groups

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Ganesalingam, Jeban ^a   Stahl, Daniel ^a   Wijesekera, Lokesh ^a   Galtrey, Clare ^a   Shaw, Christopher E ^a   Leigh, P Nigel ^a   Al Chalabi, Ammar ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BULBAR PARALYSIS; DELAYED DIAGNOSIS; FEMALE; GENE CLUSTER; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PROGNOSIS; PROGRESSIVE MUSCULAR ATROPHY; SURVIVAL RATE; AGED; CLASSIFICATION; CLUSTER ANALYSIS; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; MOTONEURON; REGRESSION ANALYSIS; SURVIVAL;

ADULT; AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CLUSTER ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; PHENOTYPE; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 70350111330     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007107     Document Type: Article

References (30)

1. Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, et al. (2002) Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 3(1): 15-21.
2. Lambrechts D, Robberecht W, Carmeliet P (2007) Heterogeneity in motor neuron disease. Trends Neurosci (10): 536-44.
3. Valdmanis PN, Rouleau GA (2008) Genetics of familial amyotrophic lateral sclerosis. Neurology 70(2): 144-52.
4. Swash M, Desai J (2000) Motor neuron disease: classification and nomenclature. Amyotroph Lateral Scler Other Motor Neuron Disord 1(2): 105-12.
5. de Carvalho M, Costa J, Swash M (2005) Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements. Amyotroph Lateral Scler Other Motor Neuron Disord 6(4): 202-12.
6. de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, et al. (2008) Electrodiagnostic criteria for diagnosis of ALS.[see comment]. Clin Neurophysiol 119(3): 497-503.
7. Zoccolella S, Beghi E, Serlenga L, Logroscino G (2005) Classification of amyotrophic lateral sclerosis cases at presentation in epidemiological studies. Neurol Sci 26(5): 330-3.
8. Hu MT, Ellis CM, Al-Chalabi A, Leigh PN, Shaw CE (1998) Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr 65(6): 950-1.
9. Katz JS, Wolfe GI, Andersson PB, Saperstein DS, Elliott JL, et al. (1999) Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology 53(5): 1071-6.
10. Wijesekera LC, Mathers S, Talman P Galtrey C, Parkinson MH, et al. (2009) Natural history and clinical features of the Flail arm and Flail leg ALS variants. Neurology 72(12): 1087-94.
11. Lazarsfeld PF, Henry NW (1968) Latent Structure Analysis. Boston: Houghton Mifflin Company. 294 p.
12. McCutcheon AL (1987) Latent Class Analysis. Newbury Park CA: Sage Publications. 104 p.
13. Vermunt JK, Magidson J (2002) Latent Class Cluster Analysis. In: Hagenaars JA, McCutcheon AL, eds. Applied Latent Class Analysis. New York: Cambridge University Press. pp 89-106.
14. Muthén LK, Muthén BO (2007) Mplus User's Guide, 5th Edition. Los Angeles, California. 673 p.
15. Ramaswamy V, DeSarbo W, Reibstein D, Robinson W (1993) An empirical pooling approach for estimating marketing elasticities with PIMS data. Mar Sci 12: 103-124.
16. Tabachnick BG, Fidell LS (2000) Using Multivariate Statistics, 4th Edition. Boston: Allyn and Bacon. 996 p.
17. Gilbert ES (1968) On discrimination using qualitative variables. J Am Stat Assoc 63: 1399-1418.
18. Moore DH (1973) Evaluation of five discrimination procedures for binary variables. J Am Stat Assoc 68: 399-404.
19. Dangond F, Hwang D, Camelo S, Pasinelli P, Frosch MP, et al. (2004) Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics 16(2): 229-39.
20. Gruzman A, Wood WL, Alpert E, Prasad MD, Miller RG, et al. (2007) Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 104(30): 12524-9.
21. Skrondal A, Rabe-Hesketh S (2004) Generalized Latent Variable Modelling: Multilevel, Longitudinal and Structural Equation Models. Boca Raton, FL: Chapman & Hall/CRC. 521 p.
22. Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 124 Suppl: 96-107.
23. Miller RG, Munsat TL, Swash M, Brooks BR (1999) Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research. J Neurol Sci 169(1-2): 2-12.
24. Visser J, de Jong JM, de Visser M (2008) The history of progressive muscular atrophy: syndrome or disease? Neurology 70(9): 723-7.
25. Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, et al. (1992) Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 115(Pt 2): 495-520.
26. Talman P, Forbes A, Mathers S (2008) Clinical phenotypes and natural progression for motor neuron disease: Analysis from an Australian database. Amyotroph Lateral Scler 18: 1-6.
27. Rosenfeld J, Swash M (2006) What's in a name? Lumping or splitting ALS, PLS, PMA, and the other motor neuron diseases. Neurology 66(5): 624-5.
28. Andersen PM, Nilsson P, Keranen ML, Forsgren L, Hagglund J, et al. (1997) Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 120(Pt 10): 1723-37.
29. Beghi E, Logroscino G, Chio A, Hardiman O, Mitchell D, et al. (2006) The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 1762(11-12): 1150-7.
30. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, et al. (2003) Are amytrophic lateral sclerosis patients cognitively normal? Neurology 60(7): 1094-7.